Herpes simplex virus (HSV) suppressive therapy in HSV-2/HIV-1 co-infected women is associated with reduced systemic CXCL10 but not genital cytokines

Схожие документы

• Transient Increase in Herpes Simplex Virus Type 2 (HSV-2)–Associated Genital Ulcers Following Initiation of Antiretroviral Therapy in HIV/HSV-2–Coinfected Individuals
  по: Fife, Kenneth H., et al.
  Опубликовано: (2016)
• Herpes Simplex Virus Suppressive Therapy Decreases Plasma and Genital HIV-1 Levels in HSV-2/HIV-1 Co-infected Women: A Randomized, Placebo-Controlled, Cross-Over Trial
  по: Baeten, Jared M., et al.
  Опубликовано: (2008)
• Screening to detect asymptomatic shedding of herpes simplex virus (HSV) in women with recurrent genital HSV infection.
  по: Barton, S E, et al.
  Опубликовано: (1986)
• Genital herpes simplex.
  по: Tummon, I. S., et al.
  Опубликовано: (1981)
• CXCL9 and CXCL10 expression are critical for control of genital herpes simplex virus type 2 infection through mobilization of HSV-specific CTL and NK cells to the nervous system
  по: Thapa, Manoj, et al.
  Опубликовано: (2008)